FDA Approves First Oral Treatment for Hereditary Angioedema Attacks
FDA Greenlights Ekterly: A Groundbreaking Oral Treatment for Hereditary Angioedema Attacks The FDA has granted approval to Ekterly (sebetralstat), a product of KalVista Pharmaceuticals. This marks a significant milestone as…
